These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2010-018980-41||International randomized phase III study on the treatment of children and adolescents with refractory or relapsed acute myeloid leukemia||2020-01-08||bad-data|
|Not reported Terminated||2013-000018-39||Clinical trial for the treatment of acute myeloid leukemia in children and adolescents||2019-03-01||due-trials|
|Ongoing||2017-002935-40||International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine||not-yet-due|
|Other||2017-003422-32||INTERNATIONAL MULTICENTER, OPEN-LABEL, PHASE 2 STUDY TO TREAT MOLECULAR RELAPSE OF PEDIATRIC ACUTE MYELOID LEUKEMIA WITH AZACITIDINE||not-yet-due|
|No trial status on register||2018-000533-13||Randomized multi-centre open-label non-inferiority phase 3 clinical trial for patients with a stage IV childhood renal tumour comparing upfront Vincristine, Actinomycin-D and Doxorubicin (VAD, standar...||bad-data|